Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

FANCI is a second monoubiquitinated member of the Fanconi anemia pathway

Abstract

Activation of the Fanconi anemia (FA) DNA damage–response pathway results in the monoubiquitination of FANCD2, which is regulated by the nuclear FA core ubiquitin ligase complex. A FANCD2 protein sequence–based homology search facilitated the discovery of FANCI, a second monoubiquitinated component of the FA pathway. Biallelic mutations in the gene coding for this protein were found in cells from four FA patients, including an FA-I reference cell line.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: FANCI monoubiquitination is site-specific and DNA damage dependent.
Figure 2: Activation of FANCI is regulated by both the FA core complex and FANCD2 monoubiquitination.
Figure 3: Biallelic mutations in KIAA1794 found in FA-I reference line and other unknown FA cells.

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Kutler, D.I. et al. Blood 101, 1249–1256 (2003).

    Article  CAS  Google Scholar 

  2. Kennedy, R.D. & D'Andrea, A.D. Genes Dev. 19, 2925–2940 (2005).

    Article  CAS  Google Scholar 

  3. Taniguchi, T. & D'Andrea, A.D. Blood 107, 4223–4233 (2006).

    Article  CAS  Google Scholar 

  4. Niedernhofer, L.J. Mol. Cell 25, 487–490 (2007).

    Article  CAS  Google Scholar 

  5. Levran, O. et al. Nat. Genet. 37, 931–933 (2005).

    Article  CAS  Google Scholar 

  6. Howlett, N.G. et al. Science 297, 606–609 (2002).

    Article  CAS  Google Scholar 

  7. Reid, S. et al. Nat. Genet. 39, 162–164 (2007).

    Article  CAS  Google Scholar 

  8. Xia, B. et al. Nat. Genet. 39, 159–161 (2007).

    Article  CAS  Google Scholar 

  9. Nijman, S.M. et al. Mol. Cell 17, 331–339 (2005).

    Article  CAS  Google Scholar 

  10. Huang, T.T. et al. Nat. Cell Biol. 8, 339–347 (2006).

    CAS  Google Scholar 

  11. Huang, T.T. & D'Andrea, A.D. Nat. Rev. Mol. Cell Biol. 7, 323–334 (2006).

    Article  CAS  Google Scholar 

  12. Matsushita, N. et al. Mol. Cell 19, 841–847 (2005).

    Article  CAS  Google Scholar 

  13. Levitus, M. et al. Blood 103, 2498–2503 (2004).

    Article  CAS  Google Scholar 

  14. Garcia-Higuera, I. et al. Mol. Cell 7, 249–262 (2001).

    Article  CAS  Google Scholar 

  15. Kalb, R. et al. Am. J. Hum. Genet. 80, 895–910 (2007).

    Article  CAS  Google Scholar 

  16. Nakanishi, K. et al. Proc. Natl. Acad. Sci. USA 102, 1110–1115 (2005).

    Article  CAS  Google Scholar 

  17. Xia, B. et al. Mol. Cell 22, 719–729 (2006).

    Article  CAS  Google Scholar 

  18. Smogorzewska, A. et al. Cell, published online 3 April 2007.

  19. Montes de Oca, R. et al. Blood 105, 1003–1009 (2005).

    Article  Google Scholar 

Download references

Acknowledgements

We thank the affected individuals and their families and the many physicians that have referred families to the International Fanconi Anemia Registry for participation in the research. We thank H. Joenje (VU University Medical Center) for providing the FA-I reference cell line EUFA592, K. Nakanishi, M. Jasin (Memorial Sloan-Kettering Cancer Center), T. Taniguchi (Fred Hutchinson Cancer Research Center) and A. D'Andrea (Dana-Farber Cancer Institute) for cell lines and reagents, Deutsche FA-Hilfe and R. Dietrich for research support, members of T.T.H.'s, D.Bar-Sagi and D. Reinberg laboratories (New York University) for technical assistance, equipment and helpful discussions, and H. Wang (SeqWright) for providing technical expertise. This work was supported in part by Deutsche Forschungsgemeinschaft grant Ha2322/2-1 and German Jose Carreras Leukemia Foundation R06/21 (H.H.), US National Institutes of Health grant R37HL32987 (A.D.A.) and New York University School of Medicine start-up funding (T.T.H.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tony T Huang.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

Top candidates from sequence-based homology search using the conserved FANCD2 monoubiquitination site LVIRK (PDF 1946 kb)

Supplementary Fig. 2

Protein sequence alignment of human FANCI and FANCD2 (PDF 953 kb)

Supplementary Fig. 3

Determining the monoubiquitination status of FANCI in FA patients with low FANCD2 protein levels (PDF 464 kb)

Supplementary Fig. 4

Sequence traces for patients F010191 and EUFA592 (PDF 425 kb)

Supplementary Table 1

FANCI genomic primers (PDF 13 kb)

Supplementary Table 2

KIAA1794 cDNA primers (PDF 10 kb)

Supplementary Methods (PDF 122 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sims, A., Spiteri, E., Sims, R. et al. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat Struct Mol Biol 14, 564–567 (2007). https://doi.org/10.1038/nsmb1252

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nsmb1252

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing